Maryland's 'Physicianeer' Push Gets $3M Boost for New Professorship

BALTIMORE, MD – February 26, 2026 – The University of Maryland School of Medicine (UMSOM) is set to accelerate its mission of merging medicine and engineering with the establishment of a new $3 million endowed professorship. The position, designed to attract a national leader in bioengineering, is funded through a powerful combination of state support and university investment, signaling a major step forward in Maryland's strategy to dominate the biomedical technology landscape.

The Edward and Jennifer St. John Endowed Professorship in Translational Biomedical Engineering and Innovation was made possible by a $1 million grant from the Maryland E-Nnovation Initiative Fund (MEIF), which was matched with an additional $2 million from the University of Maryland, Baltimore (UMB). This new role is poised to become a cornerstone of the university's efforts to rapidly translate laboratory discoveries into tangible patient treatments.

The 'Physicianeer' Revolution at CTEM

The new professorship will be a critical driver for the Edward & Jennifer St. John Center for Translational Engineering and Medicine (CTEM), a groundbreaking collaboration between UMSOM and the A. James Clark School of Engineering at the University of Maryland, College Park. Launched in 2025, CTEM was founded to break down the traditional silos separating clinicians and engineers. The center, one of only a handful of such direct partnerships in the United States, aims to create a new generation of hybrid experts dubbed 'physicianeers.'

"As Maryland continues to emerge as a national leader in biomedical technology, this matching grant will help us recruit a new scientific leader who can bring together teams of clinicians and engineers to accelerate the development of innovative medical technologies--from bench to bedside," said UMSOM Dean Mark T. Gladwin, MD. Located in Baltimore's University of Maryland BioPark, CTEM provides a collaborative space where real-world clinical challenges directly inform engineering solutions.

This interdisciplinary approach is essential for tackling modern health crises. "The complex health challenges we face today cannot be solved by any one discipline of science, engineering, or medicine," added UMB President Bruce E. Jarrell, MD, FACS. "Through CTEM, we are building a powerful, truly collaborative environment where biomedical and engineering researchers come together to translate discoveries into meaningful advances for patients."

The center's work focuses on developing next-generation technologies, and the new professor will be expected to lead efforts in advancing new imaging tools, biomaterials, AI-driven diagnostics, and novel medical devices. The ultimate goal, as Dean Gladwin noted, is to develop "better treatments and therapies for our patients."

Maryland's Strategic Investment in Biomedical Leadership

The $1 million state grant is more than just a financial contribution; it represents a key component of Maryland’s broader strategy to cement its status as a premier global hub for life sciences. The funding comes from the Maryland E-Nnovation Initiative Fund (MEIF), a program administered by the Maryland Department of Commerce specifically to foster public-private partnerships in higher education.

Since its inception in 2014, MEIF has proven to be a powerful economic engine, providing over $100.3 million in state funds to leverage more than $111.5 million in private donations. This model allows universities to establish endowed chairs and professorships that attract world-class talent, which in turn stimulates research, innovation, and commercialization. The funds can be used to pay salaries, support graduate fellowships, and purchase state-of-the-art lab equipment, creating a robust infrastructure for scientific advancement.

This strategic investment is paying dividends. The BioHealth Capital Region, which includes Maryland, was recently ranked the #3 biopharma cluster in the nation by Genetic Engineering & Biotechnology News. Furthermore, a CBRE report identified the DC/Baltimore area as the second-best market for life sciences talent in the country. This new professorship at UMSOM is a direct reflection of the state's commitment to building on this momentum, ensuring it can compete with established hubs like Boston and the San Francisco Bay Area.

The St. John Legacy: Philanthropy as a Catalyst

Central to this story of innovation is the sustained philanthropic vision of Edward and Jennifer St. John. The new professorship bears their name in recognition of their foundational and ongoing support for the university's scientific ambitions. Their commitment is a powerful example of how private giving can serve as a catalyst for long-term institutional excellence.

The St. Johns, along with the Edward St. John Foundation, provided the initial $10 million gift that, combined with a $12.75 million grant from the MPowering the State initiative, launched CTEM. Their foundation operates on the core belief that education has the power to transform lives, and its strategy focuses on funding transformational, sustainable, and unique programs.

Their support for the University of Maryland system is not limited to CTEM. The philanthropists have also funded the Edward St. John Learning and Teaching Center at College Park and supported other initiatives aimed at collaborative discovery. By backing the new endowed professorship, the St. Johns are reinforcing their long-term vision of creating a self-sustaining ecosystem of innovation where medicine and engineering converge to solve humanity's most pressing health problems.

Attracting Top Talent to a Booming Ecosystem

The search is now on for a nationally recognized leader whose work bridges bioengineering and medicine and who has a proven track record in translational research. The new professor will not only lead their own research but will also serve as a mentor and a shared resource for investigators across both the Baltimore and College Park campuses.

"We are excited to recruit a new faculty leader that can expand our impact in biomedical innovation and mentor the next generation engineers, clinicians, and physician-scientists dedicated to improving human health," said Osamah Saeedi, MD, Co-Director of CTEM and Professor of Ophthalmology and Visual Sciences at UMSOM. "This endowment furthers our commitment to building sustainable programs that benefit patients and investigators."

Maryland offers a uniquely attractive environment for such a leader. The state's bioscience industry is 38% more concentrated than the national average, and its proximity to federal agencies like the National Institutes of Health (NIH) provides unparalleled opportunities for collaboration and funding. With a skilled workforce fed by world-class institutions and a state government committed to strategic investment, the new Edward and Jennifer St. John Professor will be stepping into a dynamic ecosystem primed for groundbreaking discovery.